Ralston Shannon 13D/13G Filings for Kiromic BioPharma, Inc. (KRBP)

Ralston Shannon 13D and 13G filings for Kiromic BioPharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-05-20
5:00 pm
Purchase
2024-05-14 13D Kiromic BioPharma, Inc.
KRBP
Ralston Shannon 5,021,616
19.990%
5,021,616increase
(New Position)
Filing